Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.53
-0.30 (-4.39%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Verrica Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -17.89 | -76.58 | -67 | -24.49 | -35.08 | Upgrade
|
| Depreciation & Amortization | 0.78 | 1.27 | 0.84 | 0.72 | 0.47 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.25 | 0.08 | 2.54 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.26 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.11 | 0.07 | Upgrade
|
| Stock-Based Compensation | 3.32 | 7.16 | 14.38 | 4.99 | 6.05 | Upgrade
|
| Other Operating Activities | 2.17 | 4.85 | 0.81 | 1.83 | 1.44 | Upgrade
|
| Change in Accounts Receivable | -5.32 | 4.34 | -3.93 | -0.49 | - | Upgrade
|
| Change in Accounts Payable | 0.18 | -0.57 | 2.2 | -0.34 | 0.5 | Upgrade
|
| Change in Unearned Revenue | 0.78 | - | - | - | -0.5 | Upgrade
|
| Change in Other Net Operating Assets | -1.89 | -1.74 | 11.59 | -0.98 | -0.53 | Upgrade
|
| Operating Cash Flow | -17.63 | -60.93 | -38.58 | -18.65 | -27.58 | Upgrade
|
| Capital Expenditures | - | -0.03 | -0.36 | -0.3 | -0.88 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | 54.52 | 0.09 | Upgrade
|
| Other Investing Activities | - | - | - | -0.18 | -0.2 | Upgrade
|
| Investing Cash Flow | - | -0.02 | -0.36 | 54.04 | -1 | Upgrade
|
| Long-Term Debt Issued | - | - | 44.11 | - | 4.98 | Upgrade
|
| Long-Term Debt Repaid | -48.2 | -0.92 | -0.02 | -43.75 | -0.01 | Upgrade
|
| Net Debt Issued (Repaid) | -48.2 | -0.92 | 44.08 | -43.75 | 4.97 | Upgrade
|
| Issuance of Common Stock | 50.07 | 42.66 | 30.31 | 26.9 | 28.68 | Upgrade
|
| Other Financing Activities | -0.42 | -4 | -0.18 | -0.02 | - | Upgrade
|
| Financing Cash Flow | 1.45 | 37.73 | 74.21 | -16.87 | 33.65 | Upgrade
|
| Net Cash Flow | -16.18 | -23.22 | 35.27 | 18.52 | 5.07 | Upgrade
|
| Free Cash Flow | -17.63 | -60.95 | -38.94 | -18.95 | -28.47 | Upgrade
|
| Free Cash Flow Margin | -49.55% | -805.63% | -759.93% | -209.83% | -237.21% | Upgrade
|
| Free Cash Flow Per Share | -1.66 | -11.77 | -8.59 | -5.55 | -10.53 | Upgrade
|
| Cash Interest Paid | 5.17 | 7.23 | 3.15 | 1.79 | 2.85 | Upgrade
|
| Levered Free Cash Flow | -15.46 | -36.41 | -17.12 | -11.08 | -18 | Upgrade
|
| Unlevered Free Cash Flow | -10.62 | -30.53 | -14.64 | -9.73 | -15.32 | Upgrade
|
| Change in Working Capital | -6.25 | 2.03 | 9.86 | -1.8 | -0.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.